Strides Pharma Science Ltd Net Profit is INR 37.85 crores in Q3 FY 2020-2021

Strides Pharma Science Ltd Q3 FY20-21 Quarter Result

Strides Pharma Science Ltd Net Profit is INR 37.85 crores in Quarter 3, October – December of Financial Year 2020-2021.

Quarterly Net Earnings Year-on-Year

Strides Pharma Science Ltd Quarter Net Profit is Down by -60 % from Last Year Quarter and Net Profit of INR 37.85 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Profit was INR 93.89 crores.

Quarterly Net Sales Year-on-Year

Strides Pharma Science Ltd Quarter Sale is up 14 % from Last Quarter. Sales of 832.02 is reported in Quarter 3, October – December of Financial Year 2020-2021. In Last Year Quarter 3, October – December of Financial Year 2019-2020 Sale was 732.44

Annual Sales & Net Earning

Strides Pharma Science Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 2178.37 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 324.62 crores.


Strides Pharma Science Ltd Stock Information

SectorPharmaceuticals
IndustryPharmaceuticals – Indian – Bulk Drugs & Formln
AboutStrides Pharma Science is engaged in develops and manufactures a wide range of IP-led niche pharmaceutical products.
Latest Qaurter EPS4.222662065442857

Strides Pharma Science Ltd Stock Analysis:

Get more Quarterly Earnings Results of companies

Get complete data on Strides Pharma Science Ltd

Leave a Comment

Your email address will not be published.